What does CUSIP 75943R102 represent in this 13F holders report?

CUSIP 75943R102 is the security identifier for RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value used to aggregate holder disclosures.

How many institutions held RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in Q4 2020?

115 institutional investors reported RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value for Q4 2020. Use the holders table for investor-level position and value details.

Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY)

CUSIP: 75943R102

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, $0.01 par value
Shares outstanding: 4,389,099
Total 13F shares: 87,701,562
Share change: +2,618,214
Total reported value: $3,644,892,889
Price per share: $41.56
Number of holders: 115
Value change: +$108,159,345
Number of buys: 64
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 75943R102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	636%	27,904,963	$1,188,472,000	—	30 Sep 2020	13F
TRV GP III, LLC	13F	Company	240%	10,551,115	$449,372,000	—	30 Sep 2020	13F
FMR LLC	13F	Company	110%	4,815,879	$205,109,000	—	30 Sep 2020	13F
Casdin Capital, LLC	13F	Company	87%	3,808,894	$162,221,000	—	30 Sep 2020	13F
BVF INC/IL	13F	Company	77%	3,378,380	$143,885,000	—	30 Sep 2020	13F
EcoR1 Capital, LLC	13F	Company	73%	3,200,649	$136,316,000	—	30 Sep 2020	13F
TRV GP IV, LLC	13F	Company	64%	2,811,197	$119,729,000	—	30 Sep 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	53%	2,329,407	$99,209,000	—	30 Sep 2020	13F
Foresite Capital Management IV, LLC	13F	Company	49%	2,139,380	$91,116,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	47%	2,065,445	$87,967,000	—	30 Sep 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	46%	2,025,501	$86,266,000	—	30 Sep 2020	13F
Alphabet Inc.	13F	Company	41%	1,801,490	$76,725,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	37%	1,631,974	$69,506,000	—	30 Sep 2020	13F
Bellevue Group AG	13F	Company	30%	1,300,000	$55,367,000	—	30 Sep 2020	13F
Boxer Capital, LLC	13F	Company	29%	1,251,959	$53,321,000	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	28%	1,214,438	$48,554,000	—	30 Sep 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	24%	1,073,009	$45,699,000	—	30 Sep 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	23%	1,000,000	$42,590,000	—	30 Sep 2020	13F
BAILLIE GIFFORD & CO	13F	Company	129%	5,664,921	$42,506,000	—	30 Sep 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	18%	787,502	$33,540,000	—	30 Sep 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	16%	702,161	$29,905,000	—	30 Sep 2020	13F
HARVARD MANAGEMENT CO INC	13F	Company	12%	541,124	$23,046,000	—	30 Sep 2020	13F
BESSEMER GROUP INC	13F	Company	12%	531,124	$22,621,000	—	30 Sep 2020	13F
Avoro Capital Advisors LLC	13F	Company	11%	500,000	$21,295,000	—	30 Sep 2020	13F
FEDERATED HERMES, INC.	13F	Company	11%	500,000	$21,295,000	—	30 Sep 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	11%	486,611	$20,726,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	11%	477,888	$20,353,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	10%	436,982	$18,611,000	—	30 Sep 2020	13F
Rock Springs Capital Management LP	13F	Company	9.4%	413,674	$17,618,000	—	30 Sep 2020	13F
Artal Group S.A.	13F	Company	9.1%	400,000	$17,036,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	8.2%	358,058	$15,249,000	—	30 Sep 2020	13F
Woodline Partners LP	13F	Company	8%	351,823	$14,984,000	—	30 Sep 2020	13F
ORBIMED ADVISORS LLC	13F	Company	8%	350,000	$14,907,000	—	30 Sep 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	7.9%	344,954	$14,692,000	—	30 Sep 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	5.8%	254,509	$10,839,538	—	30 Sep 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	5.7%	250,000	$10,648,000	—	30 Sep 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	5.2%	227,392	$9,685,000	—	30 Sep 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5%	220,788	$9,404,000	—	30 Sep 2020	13F
Fernwood Investment Management, LLC	13F	Company	3.8%	165,639	$7,055,000	—	30 Sep 2020	13F
Grace Capital	13F	Company	3.7%	164,389	$7,001,000	—	30 Sep 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	3.5%	155,043	$6,604,000	—	30 Sep 2020	13F
TCW GROUP INC	13F	Company	3.2%	141,935	$6,045,000	—	30 Sep 2020	13F
Nuveen Asset Management, LLC	13F	Company	2.9%	126,039	$5,368,000	—	30 Sep 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	2.8%	123,550	$5,262,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.4%	106,359	$4,530,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	2.4%	104,325	$4,443,000	—	30 Sep 2020	13F
Logos Global Management LP	13F	Company	2.3%	100,000	$4,259,000	—	30 Sep 2020	13F
ICONIQ Capital, LLC	13F	Company	2.2%	94,697	$4,033,000	—	30 Sep 2020	13F
Bank of New York Mellon Corp	13F	Company	2%	89,053	$3,793,000	—	30 Sep 2020	13F
Ratan Capital Management LP	13F	Company	1.6%	70,000	$2,981,000	—	30 Sep 2020	13F

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) as of Q4 2020

As of 31 Dec 2020, Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,701,562 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, TRV GP III, LLC, FMR LLC, Casdin Capital, LLC, EcoR1 Capital, LLC, BlackRock Inc., BVF INC/IL, TRV GP IV, LLC, PERCEPTIVE ADVISORS LLC, and Foresite Capital Management IV, LLC. This page lists 115 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

115

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.